Navigation Links
Why we need a world social health insurance
Date:4/9/2010

ANTWERP We are in need of a social security fund on a global scale. That is what scientists of the Institute of Tropical Medicine Antwerp (ITM) argue in a Viewpoint in the leading medical journal The Lancet. Such a 'Global Fund for Health' would make the use of international donor money a lot more transparent and efficient.

Today, 44% of international health aid money cannot be traced in the budgets of the receiving countries. This doesn't necessarily mean it has disappeared in somebody's pockets, but it is unclear when nor on what it has been spent. For convenience's sake it often is assumed that governments trim down their own health expenditure in proportion to the aid they receive. An article in the same issue of The Lancet, by a group of researchers led by Christopher Murray of the Institute for Health Metrics and Evaluation (University of Washington) states that for every dollar of international health aid provided to governments, on average government health funding falls by $043𔂿14.

The Lancet asked Gorik Ooms and colleagues at the ITM to comment. Their reaction: it's not as simple as it might seem at first sight. One cannot just assert that for every euro rich countries spend on international assistance, poor countries spend one euro less. For some countries, the domestic contribution indeed goes down in response to increasing international assistance, but for other countries the domestic contribution goes up. Global averages seem to mask important variances.

There is much more work to be done to accurately trace health funding both from foreign and domestic sources, Ooms learned from a survey of 15 countries. Do governments shift money form their own health budget to other sectors as soon as aid money comes in? Do they put their own money aside, assuming external aid will run dry? Or do they spread the aid money over several years to avoid short peaks in the health service supply to their people? While at the same time tailoring their budget to give the impression that the donor money was immediately and fully used? Do governments keep the valuable hard currency, while reporting domestic expenditure as aid? Every case is different.

International assistance would be more effective if it were not as unpredictable as it is, the ITM scientists argue. The Global Fund to fight AIDS, Tuberculosis and Malaria has shown that one can pool different streams of international assistance into one stable and reliable aid source. Why don't we broaden the mandate of the Global Fund to all elements of a comprehensive primary health care, into a World Social Health Insurance fund, to which every country contributes according to its means, and receives according to its needs? The receiving countries would no longer have to shuffle money around or adapt unpredictable charity to what they perceive as their real needs.


'/>"/>

Contact: Gorik Ooms
gooms@itg.be
Institute for Tropical Medicine Antwerp
Source:Eurekalert

Related medicine news :

1. European collaboration seeks to create World Wide Web for robots
2. VisionQwest Global Group Signs Distribution Agreement with Creative Trade World, Inc.
3. United Nations Foundation Statement in Honor of World Health Day
4. Human Touch Massage Chairs Receive Exclusive Endorsement from World Federation of Chiropractic
5. Slumdog Millionaire Put Spotlight on Slums in Developing World Now, Health Visionary Helps Turn Urban Blight into Hope
6. 19 of the World's Top Asbestos and Mesothelioma Doctors Gather May 3-4, 2010 in Las Vegas
7. Autism Speaks to Celebrate Third Annual World Autism Awareness Day with Partners Around the World
8. GlobalSign EV SSL Certificates Secure Leading World Wide Brands
9. Findatopdoc.com Uses Cutting Edge Technology in Bringing the Leading Physicians of the World Directly to Your Computer For Consumers to Find a Top Doctor
10. GSK Joins Global Vaccine Alliance to Help Prevent Millions of Children from Contracting Pneumococcal Disease in the Worlds Poorest Countries
11. Tackling cardiovascular disease surge worldwide requires collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: